We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Long-term survival after infection with human immunodeficiency virus type 1 (HIV-1) among homosexual men in hepatitis B vaccine trial cohorts in Amsterdam, New York City, and San Francisco, 1978-1995.
- Authors
Koblin, B A; van Benthem, B H; Buchbinder, S P; Ren, L; Vittinghoff, E; Stevens, C E; Coutinho, R A; van Griensven, G J
- Abstract
Information on long-term survival after infection with human immunodeficiency virus type 1 (HIV-1) is limited. In hepatitis B vaccine trials in Amsterdam, New York City, and San Francisco, 362 gay men were followed up to 18 years (1978-1995). The median survival time from seroconversion was 12.1 years (95% confidence interval: 11.4, 12.9). The annual risk of dying increased at a constant rate until 8 years after seroconversion and then leveled off, suggesting a group that is relatively resistant to progression. These data provide a picture of the natural history of HIV-1 infection, especially in the era prior to widespread use of highly effective treatments.
- Publication
American journal of epidemiology, 1999, Vol 150, Issue 10, p1026
- ISSN
0002-9262
- Publication type
Journal Article
- DOI
10.1093/oxfordjournals.aje.a009926